GlassScriptPhysician profile
Matthew Raphael Rogell
NPI 1972690725
$7,112.58
in general payments reported to CMS, 2019-2025
14 companies · $621 in 2025
The $621 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,055 · 2020: $102 · 2021: $429 · 2022: $715 · 2023: $335 · 2024: $857 · 2025: $621.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,508 · Consulting Fee: $305.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,507.50 |
| Consulting Fee | $305.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $3,693.09 | 2019-2025 | Aetos Shoulder System, Real Intelligence, Redapt |
| Stryker Corporation | $1,287.16 | 2019-2025 | Mako, Aequalis Perform, Aequalis Perform Reversed |
| Pacira Pharmaceuticals Incorporated | $574.96 | 2019-2022 | |
| Depuy Synthes Sales INC. | $430.85 | 2019-2025 | Orthovisc, Monovisc, Fibergraft Bg Morsels |
| Hikma Pharmaceuticals USA | $305.33 | 2024 | Combogesic IV |
| Horizon Therapeutics Plc | $228.50 | 2020-2022 | |
| Pacira Therapeutics, INC. | $162.18 | 2019 | |
| Cook Medical LLC | $145.36 | 2025 | Cook |
| Bioventus LLC | $123.71 | 2019-2025 | Gelsyn-3, Xcell, Durolane |
| Molnlycke Health Care US, LLC | $97.32 | 2021 | |
| Abbott Laboratories | $23.67 | 2022 | |
| Vericel Corporation | $18.59 | 2023 | Maci |
| Naviswiss, INC. | $15.13 | 2024 | Naviswiss Hip Navigation |
| Heron Therapeutics, INC. | $6.73 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Rogell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.